JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Through a $35M, 15-year gift from Giovanis, researchers will tackle the most fatal aspect of cancer: how it metastasizes, or spreads, through the body. Key to this work is collaboration among many disciplines, including biology, clinical treatment of patients, physics, engineering, machine learning, and computational medicine.
“I strongly believe that tackling hard questions and inviting collaboration across disciplines empowers new thinking among researchers who, I believe, can transform how we diagnose and treat cancer,” said Giovanis.
Video
Gallery
Featured news
Ted’s Take: What is your role in health and health equity?
As we talk and plan for improvements in virtually anything, it’s important that we examine what our role in that process is and should be.
Ted’s Take: Medicare for all – HUH?
Around every national election, the phrase Medicare for All comes up. My reaction is simple: HUH? Here’s why?
JKTG-Funded Research Tackles Possible Way to Stop Spread of Breast Cancer
New JKTG Foundation-funded research identifies potential new immune system target to head off the spread of breast cancer cells. The work is from the Johns Hopkins Giovanis Institute and appears in the journal Oncogene.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133